Qube Research & Technologies LTD Nevro Corp Transaction History

Qube Research & Technologies LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$13.56 - $20.78 $246,656 - $377,988	18,190 New	18,190 $262,000
Q4 2022 Feb 14, 2023	BUY	$36.43 - $49.4 $1.26 Million - $1.71 Million	34,606 New	34,606 $1.37 Million
Q2 2022 Aug 15, 2022	BUY	$40.85 - $77.67 $789,222 - $1.5 Million	19,320 Added 97.96%	39,042 $1.71 Million
Q1 2022 May 09, 2022	SELL	$59.95 - $92.06 $496,805 - $762,901	-8,287 Reduced 29.59%	19,722 $1.43 Million
Q4 2021 Feb 01, 2022	BUY	$81.07 - $121.29 $2.27 Million - $3.4 Million	28,009 New	28,009 $2.27 Million
Q3 2021 Nov 12, 2021	SELL	$101.99 - $166.36 $379,198 - $618,526	-3,718 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$141.6 - $179.06 $526,468 - $665,745	3,718 New	3,718 $616,000
Q1 2021 May 14, 2021	SELL	$132.81 - $182.18 $588,348 - $807,057	-4,430 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$138.17 - $184.34 $97,548 - $130,144	706 Added 18.96%	4,430 $767,000
Q3 2020 Nov 12, 2020	BUY	$114.09 - $145.51 $424,871 - $541,879	3,724 New	3,724 $519,000
Q1 2020 May 15, 2020	SELL	$70.23 - $144.31 $274,037 - $563,097	-3,902 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$76.41 - $117.54 $298,151 - $458,641	3,902 New	3,902 $459,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.